Product News Header

2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

march 16, 2005
Synbiotics Corporation introduces breakthrough in Porcine CircoVirus type 2 (PCV2) detection with two ELISA tests for serum antibody or fecal antigen detection in swine

March 16, 2005- Synbiotics Corporation, the preferred resource for animal owners and professionals dedicated to the health and well-being of animals announced at VIV in Bangkok, Thailand, the launch of the first commercially available test kits for Porcine Circovirus type 2 (PCV2). The two new ELISA test kits are:

- SERELISA® PCV2 Ab Mono Blocking for use on serum and feces samples and,
- SERELISA® PCV2 Ag Capture for use on feces samples.

Porcine CircoVirus type 2 (PCV2) is the causative agent in young swine of Postweaning Multisystemic Wasting Syndrome (PMWS), and thought to be part of the Porcine Respiratory Disease Complex (PRDC). However, subclinical infection with PCV2 is commonly found in production units.

These two new tests detect antibodies in serum or feces and antigen in feces. Internal as well as field trials have demonstrated and confirmed the performances of these innovative ELISAs as sensitive and specific diagnostic tests. Samples are processed through user friendly protocols, including rapid or alternative overnight incubation. SERELISA® PCV2 Ab Mono Blocking and SERELISA® PCV2 Ag Capture can be performed in less than three hours and are useful diagnostic tools that will aid swine industry professionals in deciding on intervention strategies to control PCV2.

SYNBIOTICS Corporation will market this in certain Asian and European countries immediately and will make the product available globally once the respective government approvals are granted including in the United States upon USDA licensure.

SYNBIOTICS Corporation develops, manufactures and markets veterinary diagnostics, instrumentation and related products for the companion animal, large animal and poultry markets worldwide. For more information on SYNBIOTICS Corporation and its products, visit the company website at www.synbiotics.com.


march 16, 2009
Synbiotics Corporation launches FLU DETECT™ Antigen Capture Test Strips

March 16, 2005- Synbiotics Corporation, the preferred resource for animal owners and professionals dedicated to the health and well-being of animals is pleased to announce the launch of FLU DETECT™ Antigen Capture Test Strip Kit which was uniquely designed for veterinary use. The product, launched at VIV Asia, Bangkok, Thailand, detects all 15 H sub-types of Type A Flu. The product can be used farm side or in the laboratory for the detection of Type A Flu including H5N1, with higher sensitivity and specificity than similar products; most of which have been developed for human use.

The FLU DETECT™ Antigen Capture Test Strip Kit is an in vitro rapid assay for the surveillance of Avian Influenza Virus. This test utilizes immunochromatographic technology. A positive test result appears within 15 minutes.

Bird flu has caused severe economic losses to the Southeast Asia poultry industry. This technology helps farmers, veterinarians, public health workers and government officials to rapidly implement proper control measures, manage disease, and ultimately reduce the economic loss associated with this disease.

SYNBIOTICS Corporation will market this in certain Asian and European countries immediately and will make the product available globally once the respective government approvals are granted including in the United States upon USDA licensure.

SYNBIOTICS Corporation develops, manufactures and markets veterinary diagnostics, instrumentation and related products for the companion animal, large animal and poultry markets worldwide. For more information on SYNBIOTICS Corporation and its products, visit the company website at www.synbiotics.com.